Evidence map›Paper›PMID 36205183›Full record

ArticleJournal of orthopaedic research : official publication of the Orthopaedic Research Society2023

Interleukin-6 neutralization and regulatory T cells are additive in chondroprotection from IL-1β-induced inflammation.

Laura E Keller, Elia D Tait Wojno, Laila Begum, Lisa A Fortier

Open access · greenAbstract read
In one paragraph

Article in Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Laura E KellerDepartment of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.ORCID 0000-0002-7486-5870
Elia D Tait WojnoDepartment of Immunology, University of Washington, Seattle, Washington, USA.
Laila BegumDepartment of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
Lisa A FortierDepartment of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
Cornell University · USUniversity of Washington · US

Funding

Role of the prostaglandin D2 receptor CRTH2 in helminth-induced type 2 inflammation in the intestine.R01AI130379 · NIAID · UNIVERSITY OF WASHINGTON · PI Elia D Tait Wojno · 2017 to 2026
$3.5M
The Notch Signaling Pathway Regulates Basophil Responses During Helminth InfectionR01AI132708 · NIAID · UNIVERSITY OF WASHINGTON · PI TAIT WOJNO, ELIA D · 2017 to 2021
$2.1M
Mitoprotective therapy for treatment of ankle PTOAR01AR071394 · NIAMS · CORNELL UNIVERSITY · PI FORTIER, LISA A · 2017 to 2020
$1.8M
NIAID NIH HHS R01 AI130379NIAID NIH HHS R01 AI132708NIAMS NIH HHS R01 AR071394
6 · The paper itself

Abstract

Anti-inflammatory Regulatory T cells (Tregs) are enriched in the joints of patients with osteoarthritis (OA) compared to healthy joints. Tregs maintain homeostasis through secretion of anti-inflammatory cytokines and cell-to-cell interactions including immune checkpoint signaling. Interleukin-6 (IL-6) is a pleiotropic cytokine secreted by inflamed synoviocytes and chondrocytes that can inhibit or alter Treg function. This study tested the hypothesis that neutralization of IL-6 would enable Treg anti-inflammatory function to resolve inflammation and catabolism elicited by IL-1β in an equine chondrocyte/synoviocyte/Treg tri-culture OA model. Synoviocyte/chondrocyte co-cultures were stimulated with IL-1β, and treated with αIL-6 neutralizing antibody. Activated Tregs secreting IL-10 were added in direct contact with synoviocytes to create a tri-culture. Neutralization of IL-6 partially restored Treg anti-inflammatory functions and, in combination, reduced IL-1β-stimulated synoviocyte MMP13 expression to control levels and restored Acan expression in chondrocytes. IL-6 neutralization alone decreased Il6 expression in chondrocytes and synoviocytes, mitigating IL-6 positive feedback loop. Although Tregs were the primary producers of anti-inflammatory IL-10 and IL-4, they also produced pro-inflammatory IL-17A, as detected by ELIA, which may have been responsible for incomplete rescue of synoviocyte/chondrocyte homeostasis following IL-1β stimulation. Treg secretion of IL-10, IL-4, and IL-17A was not altered by tri-culture conditions or presence of αIL-6, therefore, it was unlikely that Treg phenotype instability occurred. The significant effect of chondrocyte/synoviocyte donor, but not Treg donor, on gene expression and IL-6 concentration in conditioned media, indicated that personalized therapy considering the patient's OA status might be needed for successful implementation of immunotherapy in the context of OA.

Indexed as

Interleukin-6OsteoarthritisAnimalsAnti-Inflammatory AgentsCells, CulturedChondrocytesCytokinesHorsesInflammationInterleukin-10Interleukin-1betaInterleukin-4T-Lymphocytes, RegulatoryAnti-Inflammatory AgentsCytokinesInterleukin-10Interleukin-1betaInterleukin-4Interleukin-6interleukin 6neutralizing antibodyosteoarthritisregulatory T cells

Identifiers

PMID36205183
PMCPMC10079781
OpenAlexW4303513539

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.